We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Prevalence of Renal Failure and Risk Factors in an Unreferred Healthy Population

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00365911
First Posted: August 18, 2006
Last Update Posted: June 2, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Prevemed-Medibo
Medical Laboratory CRI
Information provided by:
University Hospital, Ghent
  Purpose

Blood sample is taken for measurement of serum creatinine, cystatin C, clone V haemoglobin, cholesterol, urine acid, glycemia and CRP.

The medical file is gathered. There will be searched for an association between renal function and cardiovascular risk factors and risk factors by exposition to toxic substantia during work.


Condition Intervention
Healthy Procedure: Taking blood sample

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: Prevalence of Renal Failure and Risk Factors in an Unreferred Healthy Population

Further study details as provided by University Hospital, Ghent:

Primary Outcome Measures:
  • A possible association between renal clearance and found cardiovascular risk factors and risk factors by exposition to toxic substantia during work. [ Time Frame: At time T0 ]

Estimated Enrollment: 2000
Study Start Date: March 2006
Study Completion Date: December 2009
Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)
Intervention Details:
    Procedure: Taking blood sample
    A blood sample will be taken.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   20 Years to 65 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • 20-55 years
  • Male and female subjects
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00365911


Locations
Belgium
University Hospital Ghent
Ghent, Belgium, 9000
Sponsors and Collaborators
University Hospital, Ghent
Prevemed-Medibo
Medical Laboratory CRI
Investigators
Principal Investigator: Raymond Vanholder, MD, PhD University Hospital, Ghent
Principal Investigator: Wim Van Biesen, MD, PhD University Hospital, Ghent
  More Information

Additional Information:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Arjan Van Der Tol, University Hospital Ghent
ClinicalTrials.gov Identifier: NCT00365911     History of Changes
Other Study ID Numbers: 2006/038
First Submitted: August 17, 2006
First Posted: August 18, 2006
Last Update Posted: June 2, 2011
Last Verified: June 2011

Keywords provided by University Hospital, Ghent:
No specific condition

Additional relevant MeSH terms:
Renal Insufficiency
Kidney Diseases
Urologic Diseases